Coronary artery disease and outcome in acute congestive heart failure

Heart

Volumn 92, Issue 5, 2006, Pages 598-602

  Purek, L ^a   Laule Kilian, K ^a   Christ, A ^a   Klima, T ^a   Pfisterer, M E ^a   Perruchoud, A P ^a   Mueller, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; MORPHINE;

ACUTE DISEASE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DEMOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SUDDEN DEATH; SURVIVAL; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; CORONARY ARTERIOSCLEROSIS; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; PROGNOSIS;

EID: 33646261167     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.066464     Document Type: Article

References (20)

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2001;104:2996-3007.
2. Nieminen MS, Böhm M, Cowie MR, et al. The task force on acute heart failure of tfie European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384-416.
3. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
4. Bart BA, Shaw LK, McCants CB Jr, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997;30:1002-8.
5. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987;59:634-8.
6. Adams KF Jr, Dunlap SH, Sueta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;28:1781-8.
7. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84.
8. Gersh BJ, Kronmal RA, Schaff HV, et al. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older: a nonrandomized study from the coronary artery surgery study (CASS) registry. N Engl J Med 1985;313:217-24.
9. Mueller C, Scholer A, Laule Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54.
10. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-8.
11. Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analysis. JAMA 1996;276:1339-41.
12. Cleland JG, Swedberg K, Follath F, et al. Study group on diagnosis of the working group on heart failure of the European Society of Cardiology. The EuroHeart failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1. Patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
13. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
14. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off strategy") before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003;290:1593-9.
15. TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet 2001;358:951-7.
16. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Arch Intern Med 2004;141:186-95.
17. Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003;289:1117-23.
18. Pfisterer M, for the TIME Investigators. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized trial of invasive versus medical therapy in elderly patients (TIME). Circulation 2004;110:1213-8.
19. The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in angina (IONA) randomised trial. Lancet 2002;359:1269-75.
20. Fox KF, Cowie, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228-36.